dc.contributor.author
Rocamora Zúñiga, Rodrigo Alberto
dc.contributor.author
Baumgartner, Christoph
dc.contributor.author
Novitskaya, Yulia
dc.contributor.author
Hirsch, Martin
dc.contributor.author
Koren, Johannes
dc.contributor.author
Vilella Bertran, Laura
dc.contributor.author
Schulze-Bonhage, Andreas
dc.date.accessioned
2026-01-31T22:54:12Z
dc.date.available
2026-01-31T22:54:12Z
dc.date.issued
2026-01-30T14:38:29Z
dc.date.issued
2026-01-30T14:38:29Z
dc.date.issued
2026-01-30T14:38:29Z
dc.identifier
Rocamora R, Baumgartner C, Novitskaya Y, Hirsch M, Koren J, Vilella L, Schulze-Bonhage A. The spectrum of indications for ultralong-term EEG monitoring. Seizure. 2024;121:262-70. DOI: 10.1016/j.seizure.2024.08.015
dc.identifier
https://hdl.handle.net/10230/72412
dc.identifier
http://dx.doi.org/10.1016/j.seizure.2024.08.015
dc.identifier.uri
http://hdl.handle.net/10230/72412
dc.description.abstract
Purpose: We assessed clinical cases to investigate the spectrum of indications for ultra-longterm EEG monitoring using a subcutaneous implantable device in adult patients with focal epilepsy. Methods: Electronic charts were reviewed from patients undergoing ultra-longterm recordings at the European Epilepsy centers Barcelona, Freiburg and Vienna. Specific patient settings approached in the three centers were analyzed, and the main clinical question was extracted. Results from recordings were analyzed based on the specific results and information obtained. Results: 24 patients in whom ultra-longterm recordings were available were analyzed. A total of 11 main indications for subcutaneous long-term EEG recordings were identified, including the identification of active epilepsy in patients with low seizure frequency, under- and overreporting of patients, differentiation of non-epileptic from epileptic events, assessment of seizure severity, circadian and multidian rhythms of seizure occurrence, validation of treatment efficacy, improvement of patient-based reporting and medicolegal evidence for seizure freedom. This is reported with patient-specific case vignettes. Conclusion: Ultra-longterm monitoring using subcutaneous implantable EEG devices can provide relevant diagnostic and treatment information in a large spectrum of clinical situations. This is discussed considering the intrinsic limitations of the method related to spatial coverage, sensitivity and validity as a biomarker of ongoing seizures.
dc.format
application/pdf
dc.format
application/pdf
dc.relation
Seizure. 2024;121:262-70
dc.rights
© 2024 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Differential diagnosis: Epilepsy
dc.subject
Seizure cycles
dc.subject
Seizure frequency
dc.subject
Subcutaneous EEG
dc.subject
Ultra-longterm monitoring
dc.title
The spectrum of indications for ultralong-term EEG monitoring
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion